Loyal
7 known investors
Loyal develops therapeutics to help dogs live longer and healthier lives, focusing on canine aging research and longevity interventions for companion dogs.
Founders & leadership
CH
Celine HaliouainFounder & CEO
Investors · 7
In the news
- Loyal raises $100 million for dog longevity drugs - Bizwomenbizjournals.com · 2026
- Loyal Raises $100M Series C to Advance First Canine Longevity Drugpetage.com · 2026
- Loyal Raises $100M Series C, Led by age1, to Advance the First Canine Longevity Drugbusinesswire.com · 2026
- Loyal Raises $100M in Series C Fundingfinsmes.com · 2026
- Loyal raises $27M, aims to give dog owners more time with their pets | TechCrunchtechcrunch.com · 2021
- Loyal’s Series C: $100M to advance the first longevity drugloyal.com · 2020